Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
D001672:Biocompatible Materials / Q000737:chemistry / Q000378:metabolism; D002448:Cell Adhesion; D002455:Cell Division; D002460:Cell Line; D048429:Cell Size; D002470:Cell Survival; D002570:Ceruloplasmin / Q000737:chemistry* / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods*; D004705:Endocytosis / Q000502:physiology; D005290:Ferric Compounds / Q000737:chemistry* / Q000378:metabolism; D052203:Ferrosoferric Oxide; D005347:Fibroblasts / Q000166:cytology* / Q000502:physiology; D006801:Humans; D007781:Lactoferrin / Q000737:chemistry* / Q000378:metabolism; D008280:Magnetics; D008422:Materials Testing; D043942:Nanotubes / Q000737:chemistry* / Q000648:ultrastructure; D010316:Particle Size; D011956:Receptors, Cell Surface / Q000378:metabolism*
D001672:Biocompatible Materials; D005290:Ferric Compounds; D011956:Receptors, Cell Surface; C427127:superparamagnetic blood pool agent; C000499:ferric oxide; D002570:Ceruloplasmin; D007781:Lactoferrin; D052203:Ferrosoferric Oxide